CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA
Clinical trials for CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young AML patients: targeted drug combo tested in phase 2 trial
Disease control Recruiting nowThis study tests two different drug combinations for younger adults with a specific type of acute myeloid leukemia (CBF-AML). One group gets standard chemotherapy plus a targeted antibody, while the other gets the same chemotherapy plus a newer targeted pill. The goal is to see w…
Matched conditions: CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New hope for High-Risk leukemia: stem cell transplant trial launches
Disease control Recruiting nowThis study tests whether a stem cell transplant from a donor can help people with a high-risk type of acute myeloid leukemia (AML) stay cancer-free longer. Participants receive the transplant after initial chemotherapy. The trial tracks survival, relapse, and side effects in 90 n…
Matched conditions: CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC